NIST would create better ways to test and guide screening for synthetic DNA and other nucleic acids. The bill focuses on biosecurity, including risks tied to artificial intelligence, but it does not directly force labs or companies to follow new rules.
Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes. is a Senate bill in committee. The latest recorded action: Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Latest action on H.R. 3029: Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Who this affects: This bill mainly affects labs, companies, researchers, and customers involved in making or ordering synthetic DNA or other nucleic acids. It could change the tools and standards they use to screen orders for safety risks. NIST would do the technical work, while Congress would receive a report on the stakeholder group’s findings.
Why this matters: Synthetic DNA can support medicine, research, and manufacturing, but it can also create safety risks if misused. This bill would try to make screening systems more consistent and easier to test. It could guide how labs and companies build or choose screening tools. The bill does not say what the final cost or workflow impact would be.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Officially: To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
NIST would create better ways to test and guide screening for synthetic DNA and other nucleic acids. The bill focuses on biosecurity, including risks tied to artificial intelligence, but it does not directly force labs or companies to follow new rules.
Use this page to support, oppose, or ask Congress to amend HR3029. Modern Action explains what the bill does, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Sitting in Commerce
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in House
House Committee
Under House committee consideration
House Floor Vote
Voted on by House
Passed House
Approved by House
Senate Review
Sent to Senate for consideration
Latest: Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation. (7/21/2026)
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your senators when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes., then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it does, where it is in the process (committee), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around HR3029, your stance, and the reasons you choose, then lets you edit and send when ready.
